Research Scientist (Life Scientist)

We are an ambitious cyanobacterial biologics platform company seeking an outstanding candidate for the role of Research Scientist. As a highly-motivated individual, you will specialise in the development and testing of novel cyanobacterial biologics, including monoclonal antibodies, VLP vaccines, & therapeutic proteins. You will tackle a range of challenges as an integral part of the team, and demonstrate a high degree of flexibility, creativity, and initiative. You will have team leadership experience, be adaptable, work well collaboratively, and be able to thrive in a start-up environment.

• Management of lab resources; overseeing smooth functioning of the lab & key processes
• Support in vitro & preclinical evaluation of biologics, in collaboration with biochemistry team & CTO
• Working with downstream processing lead to coordinate analysis pipeline
• Updating CTO and Executive on status and timelines for biologics & preclinical material preparation
• Managing preclinical material production, in collaboration preclinical testing collaborators

• BSc or MSc in, Bioscience, Biochemistry, Microbiology, Virology, Pharmacology, Immunology or closely-related area
• At least 1 year experience in experimental work within a life sciences laboratory, such as an academic faculty, research institute, biotechnology or pharmaceutical company
• Strong analytical and problem-solving skills
• Excellent documentation and communication skills, experience working in a team environment

• ELISA-based testing & in vitro/in vivo therapeutic characterisation
• Familiarity with mAb and/or virus-like particle assembly and purification challenges
• Conducted preclinical development and/or delivery studies of mAbs, vaccines or therapeutic proteins
• Experience with mammalian cell culture & mAb expression
• Understanding & experience of antibody biophysical characterisation techniques, such as disulfide bond formation, LC/HC assembly, and glycosylation

Bondi Bio is an Australian biotechnology company developing a novel platform for the biomanufacture and delivery of biologics using bioengineered cyanobacteria. The platform offers a cost-effective and rapidly-scalable solution to produce monoclonal antibodies, vaccines, and therapeutic proteins. Bondi's food-grade cyanobacteria has the potential for distributed biomanufacturing and point-of-care needle-free delivery. Bondi is working to bring next-generation biologics to market.